FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps The Peptide Craze Ground Truths The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion Is BPC 157 Banned? Oral vs. Injectable Forms Explained